Tag Archive | "Biomarker Verification"

Webinar on Available Parkinson’s and Controls Biosamples

PPMI and The Michael J. Fox Foundation are hosting a webinar which will cover available PPMI samples and data and the process for requesting both. The webinar will take place Monday, December 15, 12 to 1 p.m. ET. Learn more and register today.

Continue reading...

PPMI Presentation at the Parkinson’s Disease Therapeutics Conference 10/29

PPMI's principal investigator, Dr. Ken Marek, will present on the initial findings of PPMI at the 8th Annual Parkinson's Disease Therapeutics Conference on October 29 in New York City.

Continue reading...

Alzforum Profiles the PPMI Expansion

Alzforum featured PPMI in an article highlighting a presentation given by PPMI?s Principal Investigator, Kenneth Marek, at the Keystone Symposia Parkinson?s Disease: Genetics, Mechanisms, and Therapeutics Conference held March 2-7 in Colorado.

Continue reading...

Important Update Regarding PPMI CSF Data

A letter from the PPMI Steering Committee regarding the status of CSF Data.

Continue reading...

New Approved Specimen Request

A request for PPMI biospecimens has recently been approved by the Biospecimen Review Committee (BRC). The researchers at the University of Salerno will investigate the utility of IGF-1 levels and dopamine transporter (DaT) uptake as a biomarker for cognitive dysfunction in early PD by measuring IGF-1 in serum samples and analyzing DaT imaging data from 400 PD and 200 healthy control subjects at baseline.

Continue reading...

New Feature: PPMI Biospecimen Inventory

An inventory of available biospecimens in PPMI can now be accessed on www.ppmi-info.org. This regularly updated table reflects the number of samples that are currently available for analysis by visit and type of sample. This is a key tool for researchers looking to request specimens to be analyzed for biomarker verification studies. This inventory table now provides researchers with real-time numbers of specimens available before submitting a request.

Continue reading...

PPMI Hits 100,000 Data Downloads Milestone

PPMI has reached an exciting milestone!  As of this week, there have been more than 100,000 downloads of the data to date.  The PPMI data has been downloaded across the globe by researchers at Universities, Research Institutions, Biotech Companies, and Pharmaceutical companies.  To get access to the PPMI data, request access here.

Continue reading...

NY Stem Cell Foundation partners with PPMI

Last week, The New York Stem Cell Foundation (NYSCF) Research Institute announced in a press release that they will partner with PPMI to generate stem cell lines from PPMI participants. The stem cell lines will used to understand the etiology and progression of the disease as compared to the existing and future biomarker data in the PPMI database.

Continue reading...

Summary of the PPMI Genetic Cohort Kick-Off Meeting

The PPMI Genetic Cohort Kick-Off Meeting took place on September 16th & 17th in New York, NY. Site Investigators, study staff, Study Core members, and members of the Steering Committee attended the two-day meeting to discuss the launch of the new Genetic Cohort in PPMI. The meeting covered the rationale for the new cohort, lessons learned from previous studies, and operational procedures.

Continue reading...

MJFF CEO Todd Sherer discusses PPMI in Medscape interview

Todd Sherer, PhD, Chief Executive Office of The Michael J Fox Foundation for Parkinson's Research, was recently interviewed by Medscape about PPMI and other promising PD research. Dr. Sherer discusses the goal of PPMI, as well as the recent publication in JAMA Neurology using PPMI data that gives evidence of proteins in the CSF levels of which were lower in people with early PD compared with age- and gender-matched controls.

Continue reading...